Work

Pos0904 Factors Associated With Switching From One Anti-tnf Agent to Another Anti-tnf, or Il17 Agent in Patient With Ankylosing Spondylitis

Year: 2021

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2021-eular.515

Authors: M. Hwang, M. Weisman, L. S. Gensler, A. Tahanan, M. Ishimori, T. Hunter, R. Bolce, J. Lisse, M. Rahbar, M. Shan, J. D. Reveille

Institutions: The University of Texas Health Science Center at Houston, Cedars-Sinai Medical Center, University of California, San Francisco, Eli Lilly (United States)

Language: English

Topic: Spondyloarthritis Studies and Treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3164898376

Cites:

Cited by: 1

Related to: 10